Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers

被引：64

作者：

Harms, Kelly L. ^{[1
,2
]}

Zhao, Lili ^{[3
]}

Johnson, Bryan ^{[4
]}

Wang, Xiaoming ^{[5
,6
]}

Carskadon, Shannon ^{[7
]}

Palanisamy, Nallasivam ^{[7
]}

Rhodes, Daniel R. ^{[4
]}

Mannan, Rahul ^{[5
,6
]}

Vo, Josh N. ^{[5
,6
]}

Choi, Jae Eun ^{[6
]}

Chan, May P. ^{[1
,6
]}

Fullen, Douglas R. ^{[1
,6
]}

Patel, Rajiv M. ^{[1
,6
]}

Siddiqui, Javed ^{[5
,6
]}

Ma, Vincent T. ^{[2
,8
]}

Hrycaj, Steven ^{[6
]}

McLean, Scott A. ^{[9
]}

Hughes, Tasha M. ^{[10
]}

Bichakjian, Christopher K. ^{[1
,2
]}

Tomlins, Scott A. ^{[4
,5
,6
]}

Harms, Paul W. ^{[1
,2
,5
,6
]}

机构：

[1] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA

[4] Strata Oncol, Ann Arbor, MI USA

[5] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA

[6] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA

[7] Henry Ford Hlth Syst, Dept Urol, Vattikuti Urol Inst, Detroit, MI USA

[8] Univ Michigan, Div Hematol & Oncol, Tepartment Internal Med, Ann Arbor, MI 48109 USA

[9] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA

[10] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA

来源：

CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 09期

关键词：

LARGE T-ANTIGEN; POLYOMAVIRUS INFECTION; EXPRESSION; MUTATIONS; SURVIVAL; AMPLIFICATION; INFILTRATION; INTEGRATION; PROFILES;

D O I：

10.1158/1078-0432.CCR-20-0864

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma that can be divided into two classes: virus-positive (VP) MCC, associated with oncogenic Merkel cell polyomavirus (MCPyV); and virus-negative (VN) MCC, associated with photodamage. Experimental Design: We classified 346 MCC tumors from 300 patients for MCPyV using a combination of IHC, ISH, and qPCR assays. In a subset of tumors, we profiled mutation status and expression of cancer-relevant genes. MCPyV and molecular profiling results were correlated with disease-specific outcomes. Potential prognostic biomarkers were further validated by IHC. Results: A total of 177 tumors were classified as VP-MCC, 151 tumors were VN-MCC, and 17 tumors were indeterminate. MCPyV positivity in primary tumors was associated with longer diseasespecific and recurrence-free survival in univariate analysis, and in multivariate analysis incorporating age, sex, immune status, and stage at presentation. Prioritized oncogene or tumor suppressor mutations were frequent in VN-MCC but rare in VP-MCC. TP53 mutation developed with recurrence in one VP-MCC case. Importantly, for the first time we find that VP-MCC and VN-MCCdisplay distinct sets of prognostic molecular biomarkers. For VP-MCC, shorter survival was associated with decreased expression of immune markers including granzyme and IDO1. For VN-MCC, shorter survival correlated with high expression of several genes including UBE2C. Conclusions: MCPyV status is an independent prognostic factor for MCC. Features of the tumor genome, transcriptome, and microenvironment may modify prognosis in a manner specific to viral status. MCPyV status has clinicopathologic significance and allows for identification of additional prognostic subgroups.

引用

页码：2494 / 2504

页数：11

共 54 条

[1] Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status [J].

Andea, Aleodor A. ;

Patel, Raj ;

Ponnazhagan, Selvarangan ;

Kumar, Sanjay ;

DeVilliers, Patricia ;

Jhala, Darshana ;

Eltoum, Isam E. ;

Siegal, Gene P. .

HUMAN PATHOLOGY, 2010, 41 (10) :1405-1412

[2] Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene [J].

Arora, Reety ;

Choi, Jae Eun ;

Harms, Paul W. ;

Chandrani, Pratik .

VIRUSES-BASEL, 2020, 12 (09)

[3] Merkel Cell Carcinoma, Version 1.2014 [J].

Bichakjian, Christopher K. ;

Olencki, Thomas ;

Alam, Murad ;

Andersen, James S. ;

Berg, Daniel ;

Bowen, Glen M. ;

Cheney, Richard T. ;

Daniels, Gregory A. ;

Glass, L. Frank ;

Grekin, Roy C. ;

Grossman, Kenneth ;

Ho, Alan L. ;

Lewis, Karl D. ;

Lydiatt, Daniel D. ;

Morrison, William H. ;

Nehal, Kishwer S. ;

Nelson, Kelly C. ;

Nghiem, Paul ;

Perlis, Clifford S. ;

Shaha, Ashok R. ;

Thorstad, Wade L. ;

Tuli, Malika ;

Urist, Marshall M. ;

Wang, Timothy S. ;

Werchniak, Andrew E. ;

Wong, Sandra L. ;

Zic, John A. ;

Hoffmann, Karin G. ;

McMillian, Nicole R. ;

Ho, Maria .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (03) :410-424

[4] Genetic profiles of different subsets of Merkel. cell carcinoma show links between combined and pure MCPyV-negative tumors [J].

Carter, Michael D. ;

Gaston, Dan ;

Huang, Weei-Yuarn ;

Greer, Wenda L. ;

Pasternak, Sylvia ;

Thai Yen Ly ;

Walsh, Noreen M. .

HUMAN PATHOLOGY, 2018, 71 :117-125

[5] Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial [J].

D'Angelo, Sandra P. ;

Bhatia, Shailender ;

Brohl, Andrew S. ;

Hamid, Omid ;

Mehnert, Janice M. ;

Terheyden, Patrick ;

Shih, Kent C. ;

Brownell, Isaac ;

Lebbe, Celeste ;

Lewis, Karl D. ;

Linette, Gerald P. ;

Milella, Michele ;

Georges, Sara ;

Shah, Parantu ;

Ellers-Lenz, Barbara ;

Bajars, Marcis ;

Guezel, Guelseren ;

Nghiem, Paul T. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)

[6] Hybrid Capture and Next-Generation Sequencing Identify Viral Integration Sites from Formalin-Fixed, Paraffin-Embedded Tissue [J].

Duncavage, Eric J. ;

Magrini, Vincent ;

Becker, Nils ;

Armstrong, Jon R. ;

Demeter, Ryan T. ;

Wylie, Todd ;

Abel, Haley J. ;

Pfeifer, John D. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (03) :325-333

[7] Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma [J].

Feldmeyer, Laurence ;

Hudgens, Courtney W. ;

Ray-Lyons, Genevieve ;

Nagarajan, Priyadharsini ;

Aung, Phyu P. ;

Curry, Jonathan L. ;

Torres-Cabala, Carlos A. ;

Mino, Barbara ;

Rodriguez-Canales, Jaime ;

Reuben, Alexandre ;

Chen, Pei-Ling ;

Ko, Jennifer S. ;

Billings, Steven D. ;

Bassett, Roland L. ;

Wistuba, Ignacio I. ;

Cooper, Zachary A. ;

Prieto, Victor G. ;

Wargo, Jennifer A. ;

Tetzlaff, Michael T. .

CLINICAL CANCER RESEARCH, 2016, 22 (22) :5553-5563

[8]

Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586

[9] Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome [J].

File, Danielle M. ;

Morgan, Katherine P. ;

Khagi, Simon .

JCO PRECISION ONCOLOGY, 2020, 4 :841-847

[10]

Garrison E., 2012, GENOMICS

← 1 2 3 4 5 6 →